News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
501,661 Results
Type
Article (48851)
Company Profile (45)
Press Release (452765)
Multimedia
Podcasts (23)
Webinars (10)
Section
Business (140542)
Career Advice (1203)
Deals (26615)
Drug Delivery (85)
Drug Development (64294)
Employer Resources (94)
FDA (12933)
Job Trends (11385)
News (249864)
Policy (26198)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
Academia (2734)
Academic (1)
Accelerated approval (5)
Adcomms (15)
Allergies (65)
Alliances (34398)
ALS (69)
Alzheimer's disease (1179)
Antibody-drug conjugate (ADC) (103)
Approvals (12962)
Artificial intelligence (169)
Autoimmune disease (14)
Automation (9)
Bankruptcy (276)
Best Places to Work (9117)
BIOSECURE Act (17)
Biosimilars (84)
Biotechnology (34)
Bladder cancer (59)
Brain cancer (26)
Breast cancer (227)
Cancer (1789)
Cardiovascular disease (140)
Career advice (985)
Career pathing (16)
CAR-T (131)
Cell therapy (332)
Cervical cancer (19)
Clinical research (52288)
Collaboration (624)
Compensation (162)
Complete response letters (24)
COVID-19 (2364)
CRISPR (29)
C-suite (196)
Cystic fibrosis (74)
Data (1822)
Decentralized trials (1)
Denatured (14)
Depression (35)
Diabetes (211)
Diagnostics (5049)
Digital health (9)
Diversity (7)
Diversity, equity & inclusion (30)
Drug discovery (83)
Drug pricing (80)
Drug shortages (16)
Duchenne muscular dystrophy (78)
Earnings (53068)
Editorial (20)
Employer branding (11)
Employer resources (82)
Events (61873)
Executive appointments (615)
FDA (13949)
Featured Employer (13)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (539)
Gene editing (73)
Generative AI (14)
Gene therapy (210)
GLP-1 (522)
Government (3553)
Grass and pollen (3)
Guidances (47)
Healthcare (14994)
Huntington's disease (15)
IgA nephropathy (20)
Immunology and inflammation (83)
Indications (27)
Infectious disease (2477)
Inflammatory bowel disease (112)
Inflation Reduction Act (9)
Influenza (43)
Intellectual property (84)
Interviews (194)
IPO (13418)
IRA (29)
Job creations (2574)
Job search strategy (859)
Kidney cancer (10)
Labor market (24)
Layoffs (361)
Leadership (5)
Legal (6527)
Liver cancer (56)
Lung cancer (271)
Lymphoma (126)
Machine learning (4)
Management (25)
Manufacturing (246)
MASH (57)
Medical device (10101)
Medtech (10103)
Mergers & acquisitions (13675)
Metabolic disorders (517)
Multiple sclerosis (70)
NASH (14)
Neurodegenerative disease (70)
Neuropsychiatric disorders (19)
Neuroscience (1604)
NextGen: Class of 2025 (4952)
Non-profit (3781)
Northern California (1923)
Now hiring (18)
Obesity (252)
Opinion (93)
Ovarian cancer (72)
Pain (72)
Pancreatic cancer (71)
Parkinson's disease (119)
Partnered (19)
Patents (196)
Patient recruitment (87)
Peanut (40)
People (45349)
Pharmaceutical (18)
Pharmacy benefit managers (17)
Phase I (15643)
Phase II (23021)
Phase III (17885)
Pipeline (1007)
Policy (99)
Postmarket research (2026)
Preclinical (6737)
Press Release (42)
Prostate cancer (85)
Psychedelics (25)
Radiopharmaceuticals (202)
Rare diseases (276)
Real estate (4542)
Recruiting (36)
Regulatory (17854)
Reports (28)
Research institute (2023)
Resumes & cover letters (199)
Rett syndrome (4)
RNA editing (2)
RSV (35)
Schizophrenia (57)
Series A (79)
Series B (49)
Service/supplier (6)
Sickle cell disease (41)
Southern California (1692)
Special edition (10)
Spinal muscular atrophy (119)
Sponsored (21)
Startups (2416)
State (2)
Stomach cancer (8)
Supply chain (46)
Tariffs (14)
The Weekly (9)
United States (16929)
Vaccines (596)
Venture capitalists (21)
Weight loss (161)
Women's health (26)
Worklife (5)
Date
Today (23)
Last 7 days (465)
Last 30 days (1782)
Last 365 days (25228)
2025 (7492)
2024 (27380)
2023 (31122)
2022 (38434)
2021 (44562)
2020 (43417)
2019 (35296)
2018 (27256)
2017 (24953)
2016 (23068)
2015 (27623)
2014 (20218)
2013 (17116)
2012 (18247)
2011 (19010)
2010 (17360)
Location
Africa (539)
Alabama (46)
Alaska (6)
Arizona (122)
Arkansas (11)
Asia (29999)
Australia (5154)
California (4381)
Canada (1624)
China (388)
Colorado (216)
Connecticut (218)
Delaware (96)
Europe (63728)
Florida (740)
Georgia (153)
Idaho (41)
Illinois (407)
India (16)
Indiana (240)
Iowa (8)
Japan (127)
Kansas (87)
Kentucky (17)
Louisiana (9)
Maine (50)
Maryland (610)
Massachusetts (2933)
Michigan (164)
Minnesota (233)
Mississippi (2)
Missouri (63)
Montana (26)
Nebraska (14)
Nevada (57)
New Hampshire (55)
New Jersey (1398)
New Mexico (16)
New York (1386)
North Carolina (735)
North Dakota (3)
Northern California (1923)
Ohio (140)
Oklahoma (13)
Oregon (20)
Pennsylvania (1040)
Puerto Rico (10)
Rhode Island (22)
South America (796)
South Carolina (18)
South Dakota (1)
Southern California (1692)
Tennessee (90)
Texas (724)
Utah (136)
Virginia (120)
Washington D.C. (59)
Washington State (505)
West Virginia (3)
Wisconsin (30)
501,661 Results for "washington state university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PharmAla Completes Shipment of LaNeo™ MDMA to the University of Washington
March 24, 2025
·
3 min read
Press Releases
Hoth Therapeutics Collaborates with Washington University on NIH Grant Application Advancing Alzheimer’s Program Using NK-1 Receptor Antagonist HT-ALZ
April 2, 2025
·
5 min read
Press Releases
Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025
April 16, 2025
·
9 min read
Press Releases
Vaxart to Present at World Vaccine Congress Washington 2025 on April 23
April 16, 2025
·
1 min read
Press Releases
Breathe BioMedical Launches Multi-Center Clinical Trial of its Breath Test for Breast Cancer at George Washington University Breast Center
February 25, 2025
·
3 min read
Press Releases
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025
April 24, 2025
·
12 min read
Interventional DiviTum(R) TKa Trial Launches at Washington University
Biovica, active in blood-based cancer monitoring, announces that a clinical trial, BettER, is being launched at Washington University School of Medicine in St. Louis.
March 13, 2024
·
2 min read
MustGrow Receives Registration Approval for TerraSante(TM) in Washington State
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”) is pleased to announce receipt of the Washington State Department of Agriculture Fertilizer Registration Certificate for its mustard plant-based TerraSanteTM crop fertilizer and soil amendment product.
November 15, 2023
·
7 min read
Press Releases
Advocates Unite in Washington D.C. to Champion Duchenne Policy Reforms
March 10, 2025
·
3 min read
Biotech Bay
Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials
Guardant Health, Inc. (Nasdaq: GH) announced its research collaborators from Washington University’s Siteman Cancer Center will lead an oral presentation today at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting highlighting the potential role of liquid biopsy in addressing racial inequities in enrollment in clinical trials and in the use of targeted therapies for advanced breast cancer.
June 3, 2024
·
5 min read
1 of 50,167
Next
